Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Wages, Salaries and Other
Others
Ratios

Neuronetics (STIM) Operating Expenses (2017 - 2026)

Neuronetics has reported Operating Expenses over the past 10 years, most recently at $25.1 million for Q1 2026.

  • Quarterly Operating Expenses fell 5.99% to $25.1 million in Q1 2026 from the year-ago period, while the trailing twelve-month figure was $102.1 million through Mar 2026, up 6.92% year-over-year, with the annual reading at $103.7 million for FY2025, 16.93% up from the prior year.
  • Operating Expenses was $25.1 million for Q1 2026 at Neuronetics, down from $26.7 million in the prior quarter.
  • Over five years, Operating Expenses peaked at $26.8 million in Q1 2025 and troughed at $19.9 million in Q1 2024.
  • The 5-year median for Operating Expenses is $21.5 million (2022), against an average of $22.6 million.
  • Year-over-year, Operating Expenses fell 8.89% in 2023 and then soared 34.12% in 2025.
  • A 5-year view of Operating Expenses shows it stood at $21.5 million in 2022, then dropped by 6.21% to $20.2 million in 2023, then skyrocketed by 30.53% to $26.4 million in 2024, then grew by 1.45% to $26.7 million in 2025, then fell by 5.97% to $25.1 million in 2026.
  • Per Business Quant, the three most recent readings for STIM's Operating Expenses are $25.1 million (Q1 2026), $26.7 million (Q4 2025), and $24.4 million (Q3 2025).